BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 29309780)

  • 21. Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing.
    Cheng DT; Prasad M; Chekaluk Y; Benayed R; Sadowska J; Zehir A; Syed A; Wang YE; Somar J; Li Y; Yelskaya Z; Wong D; Robson ME; Offit K; Berger MF; Nafa K; Ladanyi M; Zhang L
    BMC Med Genomics; 2017 May; 10(1):33. PubMed ID: 28526081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hereditary colorectal cancer].
    Park JG; Kim IJ
    Korean J Gastroenterol; 2005 Feb; 45(2):78-87. PubMed ID: 15725711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations.
    Lal G; Liu G; Schmocker B; Kaurah P; Ozcelik H; Narod SA; Redston M; Gallinger S
    Cancer Res; 2000 Jan; 60(2):409-16. PubMed ID: 10667595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hereditary cancer-associated mutations in women diagnosed with two primary cancers: an opportunity to identify hereditary cancer syndromes after the first cancer diagnosis.
    Saam J; Moyes K; Landon M; Williams K; Kaldate RR; Arnell C; Wenstrup R
    Oncology; 2015; 88(4):226-33. PubMed ID: 25503195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic testing by cancer site: stomach.
    Chun N; Ford JM
    Cancer J; 2012; 18(4):355-63. PubMed ID: 22846738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer risk associated with STK11/LKB1 germline mutations in Peutz-Jeghers syndrome patients: results of an Italian multicenter study.
    Resta N; Pierannunzio D; Lenato GM; Stella A; Capocaccia R; Bagnulo R; Lastella P; Susca FC; Bozzao C; Loconte DC; Sabbà C; Urso E; Sala P; Fornasarig M; Grammatico P; Piepoli A; Host C; Turchetti D; Viel A; Memo L; Giunti L; Stigliano V; Varesco L; Bertario L; Genuardi M; Lucci Cordisco E; Tibiletti MG; Di Gregorio C; Andriulli A; Ponz de Leon M;
    Dig Liver Dis; 2013 Jul; 45(7):606-11. PubMed ID: 23415580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes.
    Syngal S; Brand RE; Church JM; Giardiello FM; Hampel HL; Burt RW;
    Am J Gastroenterol; 2015 Feb; 110(2):223-62; quiz 263. PubMed ID: 25645574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid detection of germline mutations for hereditary gastrointestinal polyposis/cancers using HaloPlex target enrichment and high-throughput sequencing technologies.
    Kohda M; Kumamoto K; Eguchi H; Hirata T; Tada Y; Tanakaya K; Akagi K; Takenoshita S; Iwama T; Ishida H; Okazaki Y
    Fam Cancer; 2016 Oct; 15(4):553-62. PubMed ID: 26837502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double germline mutations in APC and BRCA2 in an individual with a pancreatic tumor.
    Goehringer C; Sutter C; Kloor M; Gebert J; Slater EP; Keller M; Treiber I; Ganschow P; Kadmon M; Moog U
    Fam Cancer; 2017 Apr; 16(2):303-309. PubMed ID: 27838800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endocrine tumors associated with neurofibromatosis type 1, Peutz-Jeghers syndrome and other familial neoplasia syndromes.
    Kalkan E; Waguespack SG
    Front Horm Res; 2013; 41():166-81. PubMed ID: 23652677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Germline genetic variants in men with prostate cancer and one or more additional cancers.
    Pilié PG; Johnson AM; Hanson KL; Dayno ME; Kapron AL; Stoffel EM; Cooney KA
    Cancer; 2017 Oct; 123(20):3925-3932. PubMed ID: 28657667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Familial pancreatic cancer: Concept, management and issues.
    Matsubayashi H; Takaori K; Morizane C; Maguchi H; Mizuma M; Takahashi H; Wada K; Hosoi H; Yachida S; Suzuki M; Usui R; Furukawa T; Furuse J; Sato T; Ueno M; Kiyozumi Y; Hijioka S; Mizuno N; Terashima T; Mizumoto M; Kodama Y; Torishima M; Kawaguchi T; Ashida R; Kitano M; Hanada K; Furukawa M; Kawabe K; Majima Y; Shimosegawa T
    World J Gastroenterol; 2017 Feb; 23(6):935-948. PubMed ID: 28246467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pancreatic adenocarcinoma: epidemiology and genetics.
    Flanders TY; Foulkes WD
    J Med Genet; 1996 Nov; 33(11):889-98. PubMed ID: 8950667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of high-risk germline variants for the development of pancreatic cancer: Common characteristics and potential guidance to screening guidelines.
    Bennett C; Suguitan M; Abad J; Chawla A
    Pancreatology; 2022 Sep; 22(6):719-729. PubMed ID: 35798629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for Pancreatic Cancer in High-risk Populations.
    Grover S; Jajoo K
    Gastroenterol Clin North Am; 2016 Mar; 45(1):117-27. PubMed ID: 26895684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atypical familial presentation of FAMMM syndrome with a high incidence of pancreatic cancer: case finding of asymptomatic individuals by EUS surveillance.
    Kluijt I; Cats A; Fockens P; Nio Y; Gouma DJ; Bruno MJ
    J Clin Gastroenterol; 2009 Oct; 43(9):853-7. PubMed ID: 19417680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The genetics of hereditary colon cancer.
    Rustgi AK
    Genes Dev; 2007 Oct; 21(20):2525-38. PubMed ID: 17938238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Germline variants in pancreatic cancer patients with a personal or family history of cancer fulfilling the revised Bethesda guidelines.
    Ohmoto A; Morizane C; Kubo E; Takai E; Hosoi H; Sakamoto Y; Kondo S; Ueno H; Shimada K; Yachida S; Okusaka T
    J Gastroenterol; 2018 Oct; 53(10):1159-1167. PubMed ID: 29667044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macrophage inhibitory cytokine-1/growth differentiation factor-15 in premalignant and neoplastic tumours in a high-risk pancreatic cancer cohort.
    O'Neill RS; Emmanuel S; Williams D; Stoita A
    World J Gastroenterol; 2020 Apr; 26(14):1660-1673. PubMed ID: 32327914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of ATM germline variants by the p53 mitotic centrosomal localization test in BRCA1/2-negative patients with early-onset breast cancer.
    Prodosmo A; Buffone A; Mattioni M; Barnabei A; Persichetti A; De Leo A; Appetecchia M; Nicolussi A; Coppa A; Sciacchitano S; Giordano C; Pinnarò P; Sanguineti G; Strigari L; Alessandrini G; Facciolo F; Cosimelli M; Grazi GL; Corrado G; Vizza E; Giannini G; Soddu S
    J Exp Clin Cancer Res; 2016 Sep; 35(1):135. PubMed ID: 27599564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.